Pore SK - Search Results

1

Targeting mammalian N-end rule pathway for cancer therapy.

Mattoo S, Arora M, Sharma P, Pore SK. Mattoo S, et al. Among authors: pore sk. Biochem Pharmacol. 2024 Nov 28;231:116684. doi: 10.1016/j.bcp.2024.116684. Online ahead of print. Biochem Pharmacol. 2024. PMID: 39613115 Review.

2

Encapsulation of telmisartan inside insulinoma-cell-derived extracellular vesicles outperformed biomimetic nanovesicles in modulating the pancreatic inflammatory microenvironment.

Singh A, Pore SK, Bhattacharyya J. Singh A, et al. Among authors: pore sk. J Mater Chem B. 2024 Oct 17;12(40):10294-10308. doi: 10.1039/d4tb00808a. J Mater Chem B. 2024. PMID: 39269191

3

Prospects and challenges of noncoding-RNA-mediated inhibition of heat shock protein 90 for cancer therapy.

Mattoo S, Gupta A, Chauhan M, Agrawal A, Pore SK. Mattoo S, et al. Among authors: pore sk. Biochim Biophys Acta Gene Regul Mech. 2024 Mar;1867(1):195006. doi: 10.1016/j.bbagrm.2024.195006. Epub 2024 Jan 11. Biochim Biophys Acta Gene Regul Mech. 2024. PMID: 38218528 Review.

4

Mechanism of synergistic inhibitory effect of benzyl isothiocyanate and zoledronic acid combination on breast cancer induction of osteoclast differentiation.

Hahm ER, Kim SH, Pore SK, Mathan SV, Singh RP, Singh SV. Hahm ER, et al. Among authors: pore sk. Mol Carcinog. 2024 Feb;63(2):301-313. doi: 10.1002/mc.23653. Epub 2023 Nov 3. Mol Carcinog. 2024. PMID: 37921547

5

Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective.

Pore SK, Samanta SK, Gogoi B, Hahm ER. Pore SK, et al. Front Pharmacol. 2023 Feb 24;14:1156197. doi: 10.3389/fphar.2023.1156197. eCollection 2023. Front Pharmacol. 2023. PMID: 36909197 Free PMC article. No abstract available.

6

Editorial: Immunomodulatory Nanomaterials in Cancer Theranostics.

Mukherjee S, Pramanik A, Pore SK. Mukherjee S, et al. Among authors: pore sk. Front Chem. 2021 May 13;9:691267. doi: 10.3389/fchem.2021.691267. eCollection 2021. Front Chem. 2021. PMID: 34055751 Free PMC article. No abstract available.

7

A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption.

Pore SK, Hahm ER, Kim SH, Singh KB, Nyiranshuti L, Latoche JD, Anderson CJ, Adamik J, Galson DL, Weiss KR, Watters RJ, Lee B, Kumta PN, Singh SV. Pore SK, et al. Mol Cancer Ther. 2020 Feb;19(2):420-431. doi: 10.1158/1535-7163.MCT-19-0611. Epub 2019 Nov 29. Mol Cancer Ther. 2020. PMID: 31784454 Free PMC article.

8

N-end rule pathway inhibitor sensitizes cancer cells to antineoplastic agents by regulating XIAP and RAD21 protein expression.

Pore SK, Ganguly A, Sau S, Godeshala S, Kanugula AK, Ummanni R, Kotamraju S, Banerjee R. Pore SK, et al. J Cell Biochem. 2020 Jan;121(1):804-815. doi: 10.1002/jcb.29326. Epub 2019 Aug 12. J Cell Biochem. 2020. PMID: 31407360

9

Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo.

Singh KB, Hahm ER, Pore SK, Singh SV. Singh KB, et al. Among authors: pore sk. Mol Cancer Ther. 2019 Oct;18(10):1800-1810. doi: 10.1158/1535-7163.MCT-19-0046. Epub 2019 Aug 8. Mol Cancer Ther. 2019. PMID: 31395683 Free PMC article.

10

Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.

Singh KB, Kim SH, Hahm ER, Pore SK, Jacobs BL, Singh SV. Singh KB, et al. Among authors: pore sk. Carcinogenesis. 2018 May 28;39(6):826-837. doi: 10.1093/carcin/bgy051. Carcinogenesis. 2018. PMID: 29668854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters